Rituximab (RTX) has been shown in previous work to improve thyroid-associated ophthalmopathy (TAO), but very little data is available on the effects of RTX in the target tissues. We studied the effects of RTX on peripheral lymphocytes and on the intra-orbital infiltrates in one patient with severe T...
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 131(2009), 2 vom: 15. Mai, Seite 360-5
|
|---|
| 1. Verfasser: |
Salvi, Mario
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Vannucchi, Guia,
Campi, Irene,
Currò, Nicola,
Simonetta, Simona,
Covelli, Danila,
Pignataro, Lorenzo,
Guastella, Claudio,
Rossi, Stefania,
Bonara, Paola,
Dazzi, Davide,
Ratiglia, Roberto,
Beck-Peccoz, Paolo |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2009
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Immunologic Factors
Rituximab
4F4X42SYQ6 |
|---|